KNI‐577, a Potent Small‐Sized HIV Protease Inhibitor Based on the Dipeptide Containing the Hydroxymethylcarbonyl Isostere as an Ideal Transition‐State Mimic

@article{Kiso1998KNI577AP,
  title={KNI‐577, a Potent Small‐Sized HIV Protease Inhibitor Based on the Dipeptide Containing the Hydroxymethylcarbonyl Isostere as an Ideal Transition‐State Mimic},
  author={Y. Kiso and S. Yamaguchi and H. Matsumoto and T. Mimoto and R. Kato and S. Nojima and H. Takaku and T. Fukazawa and T. Kimura and K. Akaji},
  journal={Archiv der Pharmazie},
  year={1998},
  volume={331}
}
  • Y. Kiso, S. Yamaguchi, +7 authors K. Akaji
  • Published 1998
  • Chemistry, Medicine
  • Archiv der Pharmazie
    • The development of an effective therapeutic agent for the treatment of AIDS continues to be a challenging problem. Since the discovery that the virally encoded HIV protease is vital for propagation, inhibition of this enzyme has become a major target for AIDS chemotherapy. Consequently, numerous efforts aimed at the development of potent and selective inhibitors have been undertaken[2]. Based on the substrate transition state, we designed and synthesized a novel class of HIV protease inhibitors… CONTINUE READING
    View on Wiley
    ncbi.nlm.nih.gov
    26 Citations
    Highly Influencial Citations
    1
    Background Citations
    2
    Methods Citations
    1
    26 Citations
    Citation Type

    Citation Type

    Design of small peptidomimetic HIV-1 protease inhibitors and prodrug forms
    • 17
    Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
    • 40
    Design, synthesis, and biological evaluation of anti-HIV double-drugs. conjugates of HIV protease inhibitors with a reverse transcriptase inhibitor through spontaneously cleavable linkers.
    • 26
    Synthesis and biological evaluation of prodrug-type anti-HIV agents: ester conjugates of carboxylic acid-containing dipeptide HIV protease inhibitors and a reverse transcriptase inhibitor.
    • 14
    Water-soluble prodrugs of dipeptide HIV protease inhibitors based on O-->N intramolecular acyl migration: Design, synthesis and kinetic study.
    • 33
    'Double-Drugs'--a new class of prodrug form of an HIV protease inhibitor conjugated with a reverse transcriptase inhibitor by a spontaneously cleavable linker.
    • 25
    New water-soluble prodrugs of HIV protease inhibitors based on O-->N intramolecular acyl migration.
    • 41
    Design of Potent Aspartic Protease Inhibitors to Treat Various Diseases
    • 61
    Controlled drug release: new water-soluble prodrugs of an HIV protease inhibitor.
    • 30
    Synthesis of di- and tripeptide analogues containing alpha-ketoamide as a new core structure for inhibition of HIV-1 protease.
    • 47